Press Releases

4 Years of Day Care Center bamBIOni at BioPark Regensburg

(Nr. 156) Exactly four years ago KITA bamBIOni was opened as the 40th children’s facility of St John’s Regional Association in Upper Palatinate. Since then 66 children have been cared for here. bamBIOni offers important support combining job and family at the BioPark. The institution is promoted by BioPark Regensburg GmbH.

An Innovation Prize from the BioRegions goes to Regensburg

(Nr. 155) The Council of BioRegions awarded one of three prizes at Innovation Prize 2015 to researchers at the University Hospital in Regensburg. Prof. Dr. Matthias Mack’s team was awarded for its application-oriented work in autoimmune diseases.

Current Financial Report 2014 for BioRegion Regensburg

(Nr. 154) The current development of the life science companies in the BioRegion Regensburg demonstrates a stable course in the number of companies and an increase in the number of employees. The new business figures presented here by BioPark Regensburg GmbH for 2014 are for the cluster in East Bavaria with 48 companies and 3,683 employees.

Using anti-infectious medical products for MRSA

(Nr. 153) The company rent a scientist located in Regensburg has successfully entered a flagship contract from the Bavarian Ministry of Finance in medical technology. Through the development of so-called functional surfaces an important step forward has been made in the fight against bacteria in hospitals.

10 years Council of German BioRegions

(Nr. 153) The German Council of BioRegions (AK-BioRegio) is beginning its 10 year anniversary. The BioPark has been a part of this since its foundation. Since 2007 the CEO Dr. Thomas Diefenthal has been one of three spokespersons of the AK-BioRegio in Berlin.

Regensburg BIOTECH Innovation Prize 2014

(Nr. 152) This year’s BIOTECH Innovation Prize, sponsored by BioPark Regensburg GmbH and the Patent and Attorney Chambers Dehmel & Bettenhausen, located in the BioPark, was awarded to Dr Daniel Schweizer on the occasion of Dies academicus at the University.

New methods for prevention of cancer metastasis

(Nr. 152) The Fraunhofer Project Group ITEM at BioPark Regensburg is developing successful new technologies for the earlier analysis and diagnosis of disseminated and  circulating tumour cells. This allows for future earlier personalized medical treatment.

New major shareholder at Lysando

(Transkript 13.11.2014): The medicine developer Lysando has a new major shareholder : The Thai industry conglomerate Siam Cement Group has secured a 20% share of the company.

New projects on sensor materials at Fraunhofer EMFT

The working group located in BioPark Regensburg on sensor materials from the Fraunhofer Institute for modular solid state technology has commenced various relevant projects in the life sciences.

Lord Mayor Wolbergs in GeneArt Laboratory

One of the star biotech companies in Regensburg received a high ranking visitor. Lord Mayor Wolbergs was highly impressed by the dynamic development of the company on-site which belongs to world concern Thermo Fisher Scientific.